The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial.

It came in a liquid solution with a needle so you had to make it up yourself ... In August, the agency warned that many ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

She put her order in, paid $130, and two days later, in August, a package with a vial of white powder, sterile water, and ...

Wegovy (semaglutide). EU antitrust regulators have the option to approve the acquisition, possibly with conditions, or, if ...

A doctor friend said Mounjaro was perfect for people in my situation, but a dodgy prescription left me sick and nauseous ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

Some people who take Ozempic or Wegovy (semaglutide) are using a method called “counting clicks” or microdosing to get a little more or less medication in each shot than the standard amount ...

The reality TV star says speculation about weight-loss drugs and plastic surgery is "the natural reaction to people who make ...